Quarterly reports to be a big catalyst for BLMH.c It appears that there is one thing the market is waiting for from Bloom Health Partners (CSE: BLMH), and that is Q3 earnings.
Since the company announced Q2 financials, volume has stagnated, averaging around 50K per day. However, immediately following the company’s Q2 announcement, volume shot up to around 500k, causing shares to run up 136%.
We should see Q3 earnings from Bloom at the end of this month, which I expect will cause another trading frenzy, sending shares into another rebound.
BLMH.c is currently trading at $.19, valued at $8.98 million.
https://twitter.com/BloomHealthUS